Human versus equine intramuscular antitoxin, with or without human intrathecal antitoxin, for the treatment of adults with tetanus: a 2 × 2 factorial randomised controlled trial

MLA

Van Hao, N., et al. “Human versus Equine Intramuscular Antitoxin, with or without Human Intrathecal Antitoxin, for the Treatment of Adults with Tetanus: A 2 × 2 Factorial Randomised Controlled Trial.” The Lancet Global Health, vol. 10, June 2022, pp. e862–72. EBSCOhost, https://doi.org/10.1016/s2214-109x(22)00117-6.

APA

Van Hao, N., Loan, H., Yen, L., Kestelyn, E., Hong, D., Thuy, D., Nguyen, N., Duong, H., Thuy, T., Nhat, P., Khanh, P., Dung, N., Phu, N., Phong, N., Lieu, P., Tuyen, P., Hanh, B., Nghia, H., Oanh, P., … Thwaites, C. (2022). Human versus equine intramuscular antitoxin, with or without human intrathecal antitoxin, for the treatment of adults with tetanus: a 2 × 2 factorial randomised controlled trial. The Lancet Global Health, 10, e862–e872. https://doi.org/10.1016/s2214-109x(22)00117-6

Chicago

Van Hao, N, Ht Loan, Lm Yen, E Kestelyn, Dd Hong, Db Thuy, Nt Nguyen, et al. 2022. “Human versus Equine Intramuscular Antitoxin, with or without Human Intrathecal Antitoxin, for the Treatment of Adults with Tetanus: A 2 × 2 Factorial Randomised Controlled Trial.” The Lancet Global Health 10 (June): e862–72. doi:10.1016/s2214-109x(22)00117-6.